Biosimilars
Design and Analysis of Follow-on Biologics
-
- $119.99
-
- $119.99
Publisher Description
As many biological products face losing their patents in the next decade, the pharmaceutical industry needs an abbreviated regulatory pathway for approval of biosimilar drug products, which are cost-effective, follow-on/subsequent versions of the innovator's biologic products. But scientific challenges remain due to the complexity of both the manuf
GENRE
Science & Nature
RELEASED
2013
July 29
LANGUAGE
EN
English
LENGTH
444
Pages
PUBLISHER
CRC Press
SELLER
Taylor & Francis Group
SIZE
4.2
MB
Design and Analysis of Animal Studies in Pharmaceutical Development
1998
Controversial Statistical Issues in Clinical Trials
2016
Encyclopedia of Biopharmaceutical Statistics - Four Volume Set
2018
Statistics in Drug Research
2002
Statistical Design and Analysis in Pharmaceutical Science
2018
Design and Analysis of Bioavailability and Bioequivalence Studies
2008